79 related articles for article (PubMed ID: 19541664)
1. Total cholesterol content of erythrocyte membranes and coronary atherosclerosis: an intravascular ultrasound pilot study.
Giannoglou GD; Koskinas KC; Tziakas DN; Ziakas AG; Antoniadis AP; Tentes IK; Parcharidis GE
Angiology; 2009 Dec-2010 Jan; 60(6):676-82. PubMed ID: 19541664
[TBL] [Abstract][Full Text] [Related]
2. Elevated level of lecithin:cholesterol acyltransferase (LCAT) is associated with reduced coronary atheroma burden.
Gebhard C; Rhainds D; He G; Rodés-Cabau J; Lavi S; Spence JD; Title L; Kouz S; L'Allier PL; Grégoire J; Ibrahim R; Cossette M; Guertin MC; Beanlands R; Rhéaume E; Tardif JC
Atherosclerosis; 2018 Sep; 276():131-139. PubMed ID: 30059844
[TBL] [Abstract][Full Text] [Related]
3. Effect of atherosclerotic regression on total luminal size of coronary arteries as determined by intravascular ultrasound.
Tardif JC; Grégoire J; L'Allier PL; Ibrahim R; Lavoie MA; LeMay M; Cohen E; Levesque S; Keller PF; Heinonen T; Guertin MC
Am J Cardiol; 2006 Jul; 98(1):23-7. PubMed ID: 16784914
[TBL] [Abstract][Full Text] [Related]
4. Impact of olmesartan on progression of coronary atherosclerosis a serial volumetric intravascular ultrasound analysis from the OLIVUS (impact of OLmesarten on progression of coronary atherosclerosis: evaluation by intravascular ultrasound) trial.
Hirohata A; Yamamoto K; Miyoshi T; Hatanaka K; Hirohata S; Yamawaki H; Komatsubara I; Murakami M; Hirose E; Sato S; Ohkawa K; Ishizawa M; Yamaji H; Kawamura H; Kusachi S; Murakami T; Hina K; Ohe T
J Am Coll Cardiol; 2010 Mar; 55(10):976-82. PubMed ID: 20202514
[TBL] [Abstract][Full Text] [Related]
5. Total cholesterol content of erythrocyte membranes is associated with the severity of coronary artery disease and the therapeutic effect of rosuvastatin.
Zhong Y; Tang H; Zeng Q; Wang X; Yi G; Meng K; Mao Y; Mao X
Ups J Med Sci; 2012 Nov; 117(4):390-8. PubMed ID: 23009223
[TBL] [Abstract][Full Text] [Related]
6. Independent and additive predictive value of total cholesterol content of erythrocyte membranes with regard to coronary artery disease clinical presentation.
Tziakas DN; Chalikias GK; Stakos D; Tentes IK; Papazoglou D; Thomaidi A; Grapsa A; Gioka G; Kaski JC; Boudoulas H
Int J Cardiol; 2011 Jul; 150(1):22-7. PubMed ID: 20223535
[TBL] [Abstract][Full Text] [Related]
7. Total cholesterol content of erythrocyte membranes is increased in patients with acute coronary syndrome: a new marker of clinical instability?
Tziakas DN; Kaski JC; Chalikias GK; Romero C; Fredericks S; Tentes IK; Kortsaris AX; Hatseras DI; Holt DW
J Am Coll Cardiol; 2007 May; 49(21):2081-9. PubMed ID: 17531656
[TBL] [Abstract][Full Text] [Related]
8. Heterogeneity of atherosclerotic plaque characteristics in human coronary artery disease: a three-dimensional intravascular ultrasound study.
Box LC; Angiolillo DJ; Suzuki N; Box LA; Jiang J; Guzman L; Zenni MA; Bass TA; Costa MA
Catheter Cardiovasc Interv; 2007 Sep; 70(3):349-56. PubMed ID: 17722037
[TBL] [Abstract][Full Text] [Related]
9. Remodeling is a more important determinant of lumen size than atheroma burden in left main coronary artery disease.
Berry C; Noble S; Ibrahim R; Grégoire J; Levesque S; L'allier PL; Tardif JC
Am Heart J; 2010 Jul; 160(1):188-194.e1. PubMed ID: 20598991
[TBL] [Abstract][Full Text] [Related]
10. Usefulness of follow-up low-density lipoprotein cholesterol level as an independent predictor of changes of coronary atherosclerotic plaque size as determined by intravascular ultrasound analysis after statin (atorvastatin or simvastatin) therapy.
Hong MK; Lee CW; Kim YH; Park DW; Lee SW; Park CB; Jang JS; Han KH; Cheong SS; Kim JJ; Park SW; Park SJ
Am J Cardiol; 2006 Oct; 98(7):866-70. PubMed ID: 16996864
[TBL] [Abstract][Full Text] [Related]
11. Statins, high-density lipoprotein cholesterol, and regression of coronary atherosclerosis.
Nicholls SJ; Tuzcu EM; Sipahi I; Grasso AW; Schoenhagen P; Hu T; Wolski K; Crowe T; Desai MY; Hazen SL; Kapadia SR; Nissen SE
JAMA; 2007 Feb; 297(5):499-508. PubMed ID: 17284700
[TBL] [Abstract][Full Text] [Related]
12. Relation between progression and regression of atherosclerotic left main coronary artery disease and serum cholesterol levels as assessed with serial long-term (> or =12 months) follow-up intravascular ultrasound.
von Birgelen C; Hartmann M; Mintz GS; Baumgart D; Schmermund A; Erbel R
Circulation; 2003 Dec; 108(22):2757-62. PubMed ID: 14623804
[TBL] [Abstract][Full Text] [Related]
13. Intravascular ultrasound-derived measures of coronary atherosclerotic plaque burden and clinical outcome.
Nicholls SJ; Hsu A; Wolski K; Hu B; Bayturan O; Lavoie A; Uno K; Tuzcu EM; Nissen SE
J Am Coll Cardiol; 2010 May; 55(21):2399-407. PubMed ID: 20488313
[TBL] [Abstract][Full Text] [Related]
14. Validation of a three-dimensional intravascular ultrasound imaging technique to assess atherosclerotic burden: potential for improved assessment of cardiac allograft coronary artery disease.
White JA; Pflugfelder PW; Boughner DR; Kostuk WJ
Can J Cardiol; 2003 Sep; 19(10):1147-53. PubMed ID: 14532940
[TBL] [Abstract][Full Text] [Related]
15. New set of intravascular ultrasound-derived anatomic criteria for defining functionally significant stenoses in small coronary arteries (results from Intravascular Ultrasound Diagnostic Evaluation of Atherosclerosis in Singapore [IDEAS] study).
Lee CH; Tai BC; Soon CY; Low AF; Poh KK; Yeo TC; Lim GH; Yip J; Omar AR; Teo SG; Tan HC
Am J Cardiol; 2010 May; 105(10):1378-84. PubMed ID: 20451682
[TBL] [Abstract][Full Text] [Related]
16. Abnormal glucose regulation is associated with lipid-rich coronary plaque: relationship to insulin resistance.
Amano T; Matsubara T; Uetani T; Nanki M; Marui N; Kato M; Yoshida T; Arai K; Yokoi K; Ando H; Kumagai S; Ishii H; Izawa H; Hotta N; Murohara T
JACC Cardiovasc Imaging; 2008 Jan; 1(1):39-45. PubMed ID: 19356403
[TBL] [Abstract][Full Text] [Related]
17. Do the extent and direction of arterial remodelling predict subsequent progression of coronary atherosclerosis? A serial intravascular ultrasound study.
Sipahi I; Tuzcu EM; Moon KW; Nicholls SJ; Schoenhagen P; Zhitnik J; Crowe TD; Kapadia S; Nissen SE
Heart; 2008 May; 94(5):623-7. PubMed ID: 18070944
[TBL] [Abstract][Full Text] [Related]
18. Relation of high-density lipoprotein cholesterol:apolipoprotein a-I ratio to progression of coronary atherosclerosis in statin-treated patients.
Mani P; Uno K; St John J; Tuzcu EM; Nissen SE; Nicholls SJ
Am J Cardiol; 2014 Sep; 114(5):681-5. PubMed ID: 25030535
[TBL] [Abstract][Full Text] [Related]
19. Comparison of plaque characteristics in narrowings with ST-elevation myocardial infarction (STEMI), non-STEMI/unstable angina pectoris and stable coronary artery disease (from the ADAPT-DES IVUS Substudy).
Dong L; Mintz GS; Witzenbichler B; Metzger DC; Rinaldi MJ; Duffy PL; Weisz G; Stuckey TD; Brodie BR; Yun KH; Xu K; Kirtane AJ; Stone GW; Maehara A
Am J Cardiol; 2015 Apr; 115(7):860-6. PubMed ID: 25661569
[TBL] [Abstract][Full Text] [Related]
20. Red blood cell distribution width: a strong prognostic marker in cardiovascular disease: is associated with cholesterol content of erythrocyte membrane.
Tziakas D; Chalikias G; Grapsa A; Gioka T; Tentes I; Konstantinides S
Clin Hemorheol Microcirc; 2012; 51(4):243-54. PubMed ID: 22277951
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
